News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Hilary Ellis

Articles by Hilary Ellis

100 Non-Pharmacological Interventions for Managing Abemaciclib-Associated Adverse Events in Patients With Early/Advanced HR+/HER2– Breast Cancer: A US-Based Health Care Provider Survey

ByAlexandra Vitko,Pamela K Ginex,Kelli Thoele,Qinli Lily Ma,Astra Liepa,Wambui Gathirua-Mwangi,Elyse Hall Panjic, PharmD, BCOP,Engels Chou,Jodi L Taraba,Hilary Ellis,Charlotte Clewes,Joanna de Courcy,Hope S. Rugo, MD

April 15th 2025

Latest Updated Articles

Trending on CancerNetwork

mRNA Vaccine/Pembrolizumab Shows Sustained 5-Year RFS in High-Risk Melanoma

FDA Accepts NDA for Gedatolisib in HR+/HER2–, PIK3CA Wild-Type Breast Cancer

FDA Grants Breakthrough Therapy Designation to Sofetabart Mipitecan in PROC

FDA Grants Fast Track Designation to LBL-024 in Extrapulmonary NEC

FDA Issues Guidance on MRD, CR Outcomes for Multiple Myeloma Approvals